Búsqueda | BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas

1.

A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC).

Blumenschein, G R; Smit, E F; Planchard, D; Kim, D-W; Cadranel, J; De Pas, T; Dunphy, F; Udud, K; Ahn, M-J; Hanna, N H; Kim, J-H; Mazieres, J; Kim, S-W; Baas, P; Rappold, E; Redhu, S; Puski, A; Wu, F S; Jänne, P A.

Ann Oncol ; 26(5): 894-901, 2015 May.

Artículo en Inglés | MEDLINE | ID: mdl-25722381

2.

Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.

Fossella, F V; DeVore, R; Kerr, R N; Crawford, J; Natale, R R; Dunphy, F; Kalman, L; Miller, V; Lee, J S; Moore, M; Gandara, D; Karp, D; Vokes, E; Kris, M; Kim, Y; Gamza, F; Hammershaimb, L.

J Clin Oncol ; 18(12): 2354-62, 2000 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-10856094

3.

Long-term complete remission of stage IV breast cancer after high-dose chemotherapy and autologous bone marrow transplantation.

Dunphy, F R; Spitzer, G.

Am J Clin Oncol ; 13(4): 364-6, 1990 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-2165740

4.

A phase I report of paclitaxel dose escalation combined with a fixed dose of carboplatin in the treatment of head and neck carcinoma.

Dunphy, F R; Boyd, J H; Kim, H J; Dunphy, C H; Harrison, B R; Dunleavy, T L; Rodriguez, J J; McDonough, E M; Minster, J R; Hilton, J G.

Cancer ; 79(10): 2016-23, 1997 May 15.

Artículo en Inglés | MEDLINE | ID: mdl-9149030

BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas - MTCI

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC).

Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.

Long-term complete remission of stage IV breast cancer after high-dose chemotherapy and autologous bone marrow transplantation.

A phase I report of paclitaxel dose escalation combined with a fixed dose of carboplatin in the treatment of head and neck carcinoma.

BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas - MTCI

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC).

Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.

Long-term complete remission of stage IV breast cancer after high-dose chemotherapy and autologous bone marrow transplantation.

A phase I report of paclitaxel dose escalation combined with a fixed dose of carboplatin in the treatment of head and neck carcinoma.

A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC).